📚 Wiki Guides Leucovorin / Folinic Acid

Leucovorin / Folinic Acid

Leucovorin Calcium (Folinic Acid), MOTS-c Cycle Buffer
Also known as: Folinic acid, Leucovorin calcium, 5-formyl-THF, Citrovorum factor, Wellcovorin
Brand names: Wellcovorin, Leucovorin Calcium (generic), Fusilev (levoleucovorin)
Page last reviewed

Quick Summary

Leucovorin (folinic acid) is a reduced, active form of folate used in oncology to protect against methotrexate-induced folate depletion. In the peptide research community, it has emerged as a cycle buffer for MOTS-c protocols, based on the hypothesis that MOTS-c's activation of AMPK and one-carbon metabolism pathways increases folate demand.

Ancillary Compound Established Pharmaceutical, Off-Label Community Use
Leucovorin (folinic acid) is a reduced, active form of folate used in oncology to protect against methotrexate-induced folate depletion. In the peptide research community, it has emerged as a cycle buffer for MOTS-c protocols, based on the hypothesis that MOTS-c's activation of AMPK and one-carbon metabolism pathways increases folate demand. Leucovorin supplementation during MOTS-c cycles is considered the current community "gold standard" for preventing subclinical folate depletion, particularly in users with MTHFR variants.

Folate Metabolism and MOTS-c

One-Carbon Metabolism

Folate (vitamin B9) is central to one-carbon metabolism, the cellular system that transfers single-carbon units for nucleotide synthesis, methylation reactions, and amino acid interconversion. The active forms of folate (reduced tetrahydrofolates) carry these carbon units in the cell.

MOTS-c and AMPK Activation

MOTS-c is a mitochondria-derived peptide that acts as a retrograde signal, translocating to the nucleus and activating AMPK and the folate/methionine cycle. Research suggests MOTS-c increases demand on one-carbon metabolism pathways, particularly the methylene-THF pool used for nucleotide synthesis and the methyl-THF pool used for methylation.

The Depletion Hypothesis

During high-dose or extended MOTS-c protocols, increased flux through one-carbon metabolism may deplete active folate faster than dietary intake replenishes. In individuals with MTHFR C677T or A1298C polymorphisms, where folate processing is already reduced - this depletion risk is compounded. Leucovorin bypasses the MTHFR enzyme entirely, providing pre-reduced folinic acid directly usable by the cell.

Why Leucovorin and Not Standard Folate

Standard Folate (Folic Acid)

Folic acid is synthetic and must be reduced twice, first to dihydrofolate (DHF) then to tetrahydrofolate (THF) - before cells can use it. This requires the enzyme dihydrofolate reductase (DHFR), which has limited capacity. Unmetabolized folic acid can accumulate in plasma, which has been associated with masking B12 deficiency and possibly interfering with natural killer cell function.

Methylfolate (5-MTHF)

The active methylated form of folate. Bypasses DHFR and MTHFR, generally the preferred supplement for MTHFR variants. However, 5-MTHF is committed to the methylation cycle and does not directly support the thymidylate synthesis branch of one-carbon metabolism.

Leucovorin (5-Formyl-THF)

A stable, bioavailable, pre-reduced folate that can enter one-carbon metabolism at multiple branch points, supporting both the thymidylate synthesis pool and the methylation pool. This makes it a more complete buffer for broad one-carbon demand during MOTS-c protocols than either folic acid or methylfolate alone.

Calculate your Leucovorin / Folinic Acid dose Vial strength, BAC water, exact syringe draw in IU. Free, no signup. Open Calc →

Community Protocol

Typical Use

Community protocols vary, but a representative approach:

- Timing: 5-10 mg oral leucovorin taken on MOTS-c injection days, or daily throughout the cycle - Dose range: 5 mg/day (low, most conservative) to 25 mg/day (clinical oncology support doses, generally excessive for peptide buffer use) - Form: Oral leucovorin tablets (5 mg, 10 mg, 15 mg, 25 mg strengths), widely available by prescription or through compounding pharmacies - Duration: For the length of the MOTS-c cycle

MTHFR Variants

Users confirmed heterozygous or homozygous for MTHFR C677T or A1298C should treat leucovorin supplementation during MOTS-c as more strongly indicated, not optional.

Consult a physician before use. Leucovorin is a prescription pharmaceutical in most jurisdictions. This is for research context only.


References

  • [1]Lee C, et al. "MOTS-c: A Mitochondrial-Derived Peptide Regulates Metabolism and Healthy Aging." Cell Metabolism. 2015.
  • [2]Ducker GS, Rabinowitz JD. "One-Carbon Metabolism in Health and Disease." Cell Metabolism. 2017.
  • [3]Fazili Z, et al. "Folate status and genome stability." Proceedings of the Nutrition Society. 2008.
Key Terms
Reconstitution is the process of dissolving lyophilized (freeze-dried) peptide powder with a sterile diluent to create a…
Ready to dose Leucovorin / Folinic Acid?
Get the exact syringe draw
You have read the research. Now run the math. Pick your vial size and BAC water volume, get IU draw in seconds.
Open the Calculator →
Verified Scientific Data Last audited:
Data Sources & External References
Source: peer-reviewed literature  ·  Domain: ascendpeptide.org

Suggest a Change

Leucovorin / Folinic Acid · wiki page